AMCP webinar that reviewed the FDA Reauthorization Act of 2017 (FDARA) which authorizes user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilars.
Sponsored AMCP webinar that focused on the impact of MACRA provisions on health care providers and population medication management by pharmacists, physicians, and nurses.